Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06VYE
|
||||
Former ID |
DNAP001340
|
||||
Drug Name |
Belotecan hydrocholoride
|
||||
Indication | Small-cell lung cancer [ICD9: 162.9; ICD10:C33-C34] | Approved | [551871] | ||
Target and Pathway | |||||
Target(s) | DNA topoisomerase I | Target Info | Modulator | [529023], [530110] | |
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References | |||||
Ref 529023 | Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study. Ann Oncol. 2008 Jan;19(1):123-7. Epub 2007 Sep 6. | ||||
Ref 530110 | Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009 Jul;109(7):3012-43. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.